Sitemap
Pages
- Dosage Forms
- Home Page
- Markets Served
- Our Story
- Resource Center
- Services
- Dexamethasone-Loaded Polymers for Implantable Systems
- Nanomilling Feasibility Program
- Pre-clinical Manufacturing
- Stability Indicating Method Development
- Drug / Device Combination Products
- Formulation
- Commercial Manufacturing
- Biopharmaceutical
- Micro and Nanotechnology
- Clinical Manufacturing
- Analytical Method Development and Validation
- Biopharmaceutical Analytical Services
- Physical Characterization
- ICH Stability Programs
- Drug Release Testing
- Sitemap
Posts by category
- Category: Our Blog
- 2019 Pharma Trends and Industry Outlook with Barbara Morgan
- 6 Takeaways From the 2019 FDA Complex Generic Drug Product Development Workshop: Part 1
- 6 Takeaways from the FDA’s 2018 Complex Generic Drug Product Development Workshop
- Aseptic Manufacturing and Sterile Fill-Finish for Complex Drug Products
- Highly Potent API (HPAPI) Handling: An Expert Interview with Judy Cohen
- Hot Melt Extrusion: Solubility Enhancement, Controlled Release, and More
- Lyophilization of Pharmaceuticals: An Overview
- Nanomilling: A Key Option for Formulating Water-Insoluble APIs
- Orphan Drug Product Development: Incentives and Outsourcing Considerations
- Overcoming Solubility Challenges: Techniques to Improve Dissolution Rate and Increase Bioavailability
- How Personalized Medicine is Evolving the CDMO Landscape
- The FDA’s Recent Uptick in Ophthalmic NDA & BLA Approvals
- Understanding Analytical Method Validation with Laurie Goldman
- What are Complex Drug Products and Why Should You Care?
- Why the FDA Loves Complex Generic Drug Products
- Category: Presentations/Webinars
- Aseptic Nanomilling Presentation
- Implantable Systems and Microparticle Depots Webinar
- Insoluble API’s Scaring You? Don’t Be Afraid of Nanotechnology!
- Microparticles as Controlled Release Drug Delivery Systems Presentation
- Overcoming Challenges in Ophthalmic Drug Delivery including Bioavailability and Sterility
- Category: Published Articles
- A Review Of Sunscreen Safety And Efficacy
- American Pharma Review – An Overview of the Zeta Potential – Part 1: The Concept
- Ask the Expert: Analytical Method Validation
- Bioavailability Enhancement: A Novel Spray-Drying Technology to Improve the Bioavailability of Biopharmaceutical Classification System Class II Molecules
- Charged Interfaces in Polar & Non-Polar Media & the Concept of the Zeta Potential
- Combination Products for Medical Device Developers
- Comments On Biopharmaceutical Classification System And Formulation Development
- Dissolving Solubility Challenges
- Drug-Eluting Devices: Delivering on Drug Delivery’s Combined Potential
- Dry Eye Syndrome: A Review & Novel Formulation Approach
- Early-Stage Formulation Considerations
- Forced Degradation as an Integral Part of HPLC Stability-Indicating Method Development
- Identication Of Human Natriuretic Hormone Cain Et Al PNAS October 31, 2007
- Improving Bioavailability & Solubility: Chemical & Physical Modification vs. Formulation Development
- The Issues & Challenges Involved in In Vitro Release Testing for Semi-Solid Formulations
- Looking Beyond the Solubility Horizon
- Manufacture Of Microspheres As Carrier Particles For Active Biomolecules
- Microbicides: A promising strategy to reduce HIV infection
- Microbicides For HIV AIDS Electrophoretic Fingerprinting The H9 Cell Model System
- Microcapsules With Liquid Cores And Polymer Shells Made By Solvent Evaporation
- Microencapsulated Non-aqueous Dispersions
- Nanomilling: Shaping the Solubility and Bioavailability of Today’s Therapeutics
- Nebulizable Nanoparticle Dispersions: A Novel Inhalable Dosage Form
- Observations on Nanotechnology-based Drug Delivery Approaches: Translating Nanotechnology from Bench to Pharmaceutical Market
- Outsourcing Formulation Development & Manufacturing: CDMOs Shift to Offer More Specialized Services
- Overcoming Complexity – Trends Shaping The Drug Formulation Industry
- Overcoming the Challenges in Drug-Device Combination Product Formulation
- Particle Sciences — An API’s Characteristics Determine the Best Approach to Improving Solubility
- Particle Sciences’ Barbara Morgan on Pharma and Diversity
- Particle Sciences & Horiba Instruments: Providing Clients a Total Solution
- Particle Sciences is Highlighted in the CHAARM Newsletter 2013
- Particle Sciences Positions Itself as a Bioavailability Tool for Most Drug Forms
- Particle Sciences: Providing Formulation & Analytic Services to Meet Demanding Drug Delivery Challenges
- Particle Sciences — Targeted Drug Products Using Nano Formulations
- Particle Size Distribution: Light Microscopic Determination of Particle Size Distribution in an Aqueous Gel.
- Patient-Centric Drug Development Comes of Age
- pH-sensitive Microgels
- Phase III Modeling AIDS 06
- Regulatory Challenges In Microbicide Development
- Selection of Active Pharmaceutical Ingredients (APIs) and Excipients for Topical Formulations
- Solid Dosage Forms – Polymers for Solid Oral Dosage Forms
- Solid Lipid Nanoparticles: Drug Delivery Technology September 2009 Vol 9 No 8. Solid Lipid Nanoparticles for the Delivery of Pharmaceutical Actives.
- Targeted Delivery Of Actives: Cationic Nanoparticles For Use In Hair And Skin Products
- The Big Freeze: Obtaining the Best Results from Lyophilization
- The Central Role Of Analytic Method Development And Validation In Pharmaceutical Development
- The Demands of the Perfect Dose
- The relentless effort to curtail the HIV pandemic continues as researchers aggressively investigate alternative prevention tools
- The Zeta Potential & its Use in Pharmaceutical Applications – Part 2: Measurement Techniques & Uses
- TMC120 Blocks HIV-1 Infection In Cellular And Human Cervical Tissue Models
- Update from CHAARM, a Particle Sciences Client
- Vaccine Technologies & the Rationale for New Nanoparticle Formulations
- Women’s Equality Day: Pharma is Leveling the Playing Field
- Category: Scientific Publications
- Acoustic Attenuation Spectroscopy
- Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen
- Concentrations of Dapivirine In Rhesus And Rabbit Following Gel Administration
- Controlled Release of Antiretroviral Drugs from Ethylene-vinylacetate
- Ethylene-vinylacetate Intravaginal Rings for Zero-order Release of an Antiretroviral Drug
- Ethylene‐vinylacetate Intravaginal Rings for the Prolonged Release of Antiretroviral Drug UC781 & Contraceptive Hormone Levonorgestrel
- Future Of HIV Prevention Prospects For An Effective Anti HIV Microbicide
- Handbook of Non-Invasive Drug Delivery Systems Edited by Dr. Vitthal S. Kulkarni
- Micro And Nano-Encapsulation Of Water And Oil Soluble Actives For Cosmetic And Pharmaceutical Applications
- Microbicides for HIV/AIDS. 2. Electrophoretic Fingerprinting of CD4+ T-Cell Model Systems
- Microbicides for HIV/AIDS. 3. Observation of Apparent Dynamic Protonation and Deprotonization in CD4+ T-Cell Model Systems
- Microbicides for the prevention of HIV infection in women: an overview of recent trials
- Novel Formulation of Glycerin 1% Artificial Tears Extends Tear Film Break-Up Time Compared with Systane Lubricant Eye Drops
- Category: Technical Briefs
- Analytical Method Development and Validation
- Biopharmaceutical Classification System
- Cleanroom Operations
- Combination Devices
- Considerations in Particle Sizing – Part 1: Classification of the Various Sizing Techniques
- Considerations in Particle Sizing – Part 2: Specifying a Particle Size Analyzer
- Cubic Phase Particles
- Development and Validation of In Vitro Release Testing for Semisolid Formulations
- Dissolution Testing for OSD
- Dissolving Films
- Drug Substance Solid State Characterization
- Emulsion Stability and Testing
- Emulsions and Emulsifications
- Encapsulation
- Glossary of Nanotech
- Glossary of Polymer Terms
- Hot Melt Extrusion
- In Vitro Dissolution Testing For Solid Oral Dosage Forms
- Mass Spectrometry in Bioanalysis
- Mechanical Dispersing of Insoluble APIs
- Nanotechnology – New Name – Old Science
- Overview of the Zeta Potential
- Particle Size Distribution and Its Measurement
- Phase Behavior of Surface-Active Solutes
- Physical Stability of Disperse Systems
- Potent Compound Handling Operations
- Process Analytical Technology
- Protein Structure: Primary, Secondary, Tertiary, Quatemary Structures
- Quality by Design
- Sampling of Powders
- Skin and Nail: Barrier Function, Structure, and Anatomy Considerations for Drug Delivery
- Solid Lipid Nanoparticles
- Solid Solutions and Dispersions
- Solubility – Ideal Solubility & Solubility Models
- Surfactants
- The Patent Process